State Street Corp Harmony Biosciences Holdings, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, State Street Corp holds 1,580,815 shares of HRMY stock, worth $61.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,580,815

Previous 1,240,598 27.42%

Holding current value

$61.6 Million

Previous $49.6 Million 9.75%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.86 - $41.49 $10.8 Million - $14.1 Million	340,217 Added 27.42%	1,580,815 $54.4 Million
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $987,000 - $1.31 Million	-32,900 Reduced 2.58%	1,240,598 $49.6 Million
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $635,145 - $727,738	-22,046 Reduced 1.7%	1,273,498 $38.4 Million
Q1 2024 May 15, 2024	SELL	$29.93 - $35.06 $1.94 Million - $2.28 Million	-64,903 Reduced 4.77%	1,295,544 $43.5 Million
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $2.55 Million - $4.49 Million	132,986 Added 10.83%	1,360,447 $43.9 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $2.76 Million - $3.38 Million	86,527 Added 7.58%	1,227,461 $40.2 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $2.97 Million - $3.64 Million	97,337 Added 9.33%	1,140,934 $40.1 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $2.18 Million - $3.82 Million	70,814 Added 7.28%	1,043,597 $34.1 Million
Q4 2022 Feb 14, 2023	SELL	$45.4 - $60.91 $4.72 Million - $6.34 Million	-104,043 Reduced 9.66%	972,783 $53.6 Million
Q3 2022 Nov 15, 2022	BUY	$42.06 - $55.45 $5.57 Million - $7.35 Million	132,491 Added 14.03%	1,076,826 $47.7 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $3.9 Million - $6.06 Million	116,154 Added 14.03%	944,335 $46.1 Million
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $1.74 Million - $2.68 Million	52,498 Added 6.77%	828,181 $40.3 Million
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $12.9 Million - $16.6 Million	378,825 Added 95.46%	775,683 $33.1 Million
Q3 2021 Nov 15, 2021	BUY	$25.68 - $38.61 $2.42 Million - $3.63 Million	94,068 Added 31.07%	396,858 $15.2 Million
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $5.59 Million - $7.2 Million	215,312 Added 246.13%	302,790 $8.55 Million
Q1 2021 May 17, 2021	BUY	$27.56 - $40.37 $129,532 - $189,739	4,700 Added 5.68%	87,478 $2.89 Million
Q4 2020 Feb 16, 2021	BUY	$31.74 - $51.34 $2.63 Million - $4.25 Million	82,778 New	82,778 $2.99 Million

Others Institutions Holding HRMY

# of Institutions

254

Shares Held

45.6M

Call Options Held

111K

Put Options Held

46.9K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.31B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Harmony Biosciences Holdings, Inc. Transaction History